Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
109.65 USD | -2.18% |
|
-1.27% | +18.71% |
05:34pm | Ny ag James- my office and 48 ags secured $202 million from Gilead Sciences - X post | RE |
07-14 | Gilead Says Yeztugo Shows Broad Effectiveness, Tolerability for Diverse HIV Prevention | MT |
EPS & Dividend: Gilead Sciences, Inc.
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Dividend per Share 2 | 2.72 | 2.84 | 2.92 | 3 | 3.08 | 3.246 | 3.396 | 3.523 |
Rate of return | 4.67% | 3.91% | 3.4% | 3.7% | 3.33% | 2.9% | 3.03% | 3.14% |
EPS 2 | 0.1 | 4.93 | 3.64 | 4.5 | 0.38 | 5.443 | 5.612 | 7.522 |
Distribution rate | 2,720% | 57.6% | 80.2% | 66.7% | 811% | 59.6% | 60.5% | 46.8% |
Reference price 2 | 58.26 | 72.61 | 85.85 | 81.01 | 92.37 | 112.09 | 112.09 | 112.09 |
Nbr of stocks (in thousands) | 1,253,528 | 1,254,384 | 1,254,244 | 1,246,042 | 1,246,266 | 1,243,929 | - | - |
Announcement Date | 04/02/21 | 01/02/22 | 02/02/23 | 06/02/24 | 11/02/25 | - | - | - |
1USD in Million2USD
Estimates
Past dividends: Gilead Sciences, Inc.
12/06/2025 | Quarterly 0.79 USD |
13/03/2025 | Quarterly 0.79 USD |
12/12/2024 | Quarterly 0.77 USD |
12/09/2024 | Quarterly 0.77 USD |
13/06/2024 | Quarterly 0.77 USD |
13/03/2024 | Quarterly 0.77 USD |
13/12/2023 | Quarterly 0.75 USD |
13/09/2023 | Quarterly 0.75 USD |
13/06/2023 | Quarterly 0.75 USD |
13/03/2023 | Quarterly 0.75 USD |
13/12/2022 | Quarterly 0.73 USD |
13/09/2022 | Quarterly 0.73 USD |
13/06/2022 | Quarterly 0.73 USD |
13/03/2022 | Quarterly 0.73 USD |
13/12/2021 | Quarterly 0.71 USD |
13/09/2021 | Quarterly 0.71 USD |
13/06/2021 | Quarterly 0.71 USD |
11/03/2021 | Quarterly 0.71 USD |
13/12/2020 | Quarterly 0.68 USD |
13/09/2020 | Quarterly 0.68 USD |
Upcoming events: Gilead Sciences, Inc.
04/08/2025 | Q2 2025 Earnings Release (Projected) |
22/10/2025 | Q3 2025 Earnings Release (Projected) |
09/02/2026 | Q4 2025 Earnings Release (Projected) |
22/04/2026 | Q1 2026 Earnings Release (Projected) |
Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
---|---|---|---|---|---|---|
2.9% | 3.03% | 20.59x | 6.23x | 5.27x | ||
0.74% | 0.83% | 37.59x | 27.56x | 12.4x | ||
3.35% | 3.44% | 15.03x | 5.04x | 4.2x | ||
3.42% | 3.58% | 27.31x | 48.87x | 6.56x | ||
2.97% | 3.46% | 17.01x | 9.6x | 6.14x | ||
3.83% | 3.92% | 14.2x | 5.41x | 3.5x | ||
3.25% | 3.4% | 17.18x | 5.11x | 4.63x | ||
2.24% | 2.36% | 22.67x | 4.93x | 4.21x | ||
3.85% | 4.04% | 10.72x | 3.79x | 3.48x | ||
3.23% | 3.39% | 22.71x | 18.18x | 5.81x | ||
Average | 2.98% | 3.15% | 20.50x | 13.47x | 5.62x | |
Weighted average by Cap. | 2.65% | 2.81% | 23.13x | 16.65x | 6.71x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition